Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells

Molecular Nutrition and Food Research

Volumn 52, Issue 8, 2008, Pages 930-939

  Lin, Chih Li ^a   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

( ) Epigallocatechin 3 gallate; Akt; AMP activated protein kinase; Insulin; Insulin receptor substrate 1

Indexed keywords

ADENYLATE KINASE; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; DRUG EFFECT; HUMAN; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENYLATE KINASE; CARCINOMA, HEPATOCELLULAR; CATECHIN; CELL LINE, TUMOR; GLUCOSE; HUMANS; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 54549088739     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700437     Document Type: Article

References (42)

1. Rossetti, L., Glucose toxicity: The implications of hyperglycemia in the pathophysiology of diabetes mellitus. Clin. Invest. Med. 1995, 18, 255-260.
2. Kim, S. P., Ellmerer, M., Van Citters, G. W., Bergman, R. N., Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 2003, 52, 2453-2460.
3. Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. et al., Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 2000, 6, 77-86.
4. Thirone, A. C., Huang, C., Klip, A., Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol. Metab. 2006, 17, 72-78.
5. Petersen, K. F., Shulman, G. I., Etiology of insulin resistance. Am. J. Med. 2006, 119, S10-S16.
6. Taniguchi, C. M., Ueki, K., Kahn, R., Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 2005, 115, 718-727.
7. Hale, P. J., Horrocks, P. M., Wright, A. D., Fitzgerald, M. G. et al., Xiaoke tea, a Chinese herbal treatment for diabetes mellitus. Diabet. Med. 1989, 6, 675-676.
8. Wolfram, S., Wang, Y., Thielecke, F., Anti-obesity effects of green tea: From bedside to bench. Mol. Nutr. Food Res. 2006, 50, 176-187.
9. Wu, L. Y., Juan, C. C., Hwang, L. S., Hsu, Y. P. et al., Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur. J. Nutr. 2004, 43, 116-124.
10. Lin, J. K., Lin, C. L., Liang, Y. C., Lin-Shiau, S. Y., Juan, I. M., Survey of catechins, gallic acid, and methylxanthines in green, Oolong, Pu-erh, and black teas. J. Agric. Food Chem. 1998, 46, 3635-3642.
11. Anderson, R. A., Polansky, M. M., Tea enhances insulin activity. J. Agric. Food Chem. 2002, 50, 7182-7186.
12. Wolfram, S., Raederstorff, D., Preller, M., Wang, Y. et al., Epigallocatechin gallate supplementation alleviates diabetes in rodents. J. Nutr. 2006, 136, 2512-2518.
13. Anton, S., Melville, L., Rena, G., Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell. Signal. 2007, 19, 378-383.
14. Waltner-Law, M. E., Wang, X. L., Law, B. K., Hall, R. K. et al., Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J. Biol. Chem. 2002, 277, 34933-34940.
15. Collins, Q. F., Liu, H. Y., Pi, J., Liu, Z. et al., Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 59-AMP-activated protein kinase. J. Biol. Chem. 2007, 282, 30143-30149.
16. Wolfram, S., Raederstorff, D., Preller, M., Wang, Y. et al., Epigallocatechin gallate supplementation alleviates diabetes in rodents. J. Nutr. 2006, 136, 2512-2518.
17. Gupta, D., Varma, S., Khandelwal, R. L., Long-term effects of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt/PKB. J. Cell. Biochem. 2007, 100, 593-607.
18. Nakajima, K., Yamauchi, K., Shigematsu, S., Ikeo, S. et al., Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J. Biol. Chem. 2000, 275, 20880-20886.
19. Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H. et al., Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 2002, 277, 1531-1537.
20. Zang, M., Zuccollo, A., Hou, X., Nagata, D. et al., AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 2004, 279, 47898-47905.
21. Jakobsen, S. N., Hardie, D. G., Morrice, N., Tornqvist, H. E., 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 2001, 276, 46912-46916.
22. Newgard, C. B., Brady, M. J., O'Doherty, R. M., Saltiel, A. R., Organizing glucose disposal: Emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 2000, 49, 1967-1977.
23. Yamashita, R., Saito, T., Satoh, S., Aoki, K. et al., Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2. Endocr. J. 2005, 52, 727-733.
24. Rosen, P., Nawroth, P. P., King, G., Moller, W. et al., The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 2001, 17, 189-212.
25. West, I. C., Radicals and oxidative stress in diabetes. Diabet. Med. 2000, 17, 171-180.
26. Osawa, T., Kato, Y., Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann. N. Y. Acad. Sci. 2005, 1043, 440-451.
27. Rudich, A., Tirosh, A., Potashnik, R., Khamaisi, M., Bashan, N., Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 1999, 42, 949-957.
28. Li, R. W., Douglas, T. D., Maiyoh, G. K., Adeli, K., Theriault, A. G., Green tea leaf extract improves lipid and glucose homeostasis in a fructose-fed insulin-resistant hamster model. J. Ethnopharmacol. 2006, 104, 24-31.
29. Koyama, Y., Abe, K., Sano, Y., Ishizaki, Y. et al., Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Med. 2004, 70, 1100-1102.
30. Hartman, M. E., Villela-Bach, M., Chen, J., Freund, G. G., Frap-dependent serine phosphorylation of IRS-1 inhibits IRS-1 tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 2001, 280, 776-781.
31. Liu, Y. F., Herschkovitz, A., Boura-Halfon, S., Ronen, D. et al., Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol. Cell. Biol. 2004, 24, 9668-9681.
32. Mussig, K., Staiger, H., Fiedler, H., Moeschel, K. et al., Shp2 is required for protein kinase C-dependent phosphorylation of serine 307 in insulin receptor substrate-1. J. Biol. Chem. 2005, 280, 32693-32699.
33. Nakatani, Y., Kaneto, H., Kawamori, D., Hatazaki, M. et al., Modulation of the JNK pathway in liver affects insulin resistance status. J. Biol. Chem. 2004, 279, 45803-45809.
34. Hwang, J. T., Park, I. J., Shin, J. I., Lee, Y. K. et al., Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 2005, 338, 694-699.
35. Considine, R. V., Nyce, M. R., Allen, L. E., Morales, L. M. et al., Protein kinase C is increased in the liver of humans and rats with noninsulin-dependent diabetes mellitus: An alteration not due to hyperglycemia. J. Clin. Invest. 1995, 95, 2938-2944.
36. Chiang, C. T., Weng, M. S., Lin-Shiau, S. Y., Kuo, K. L. et al., Pu-erh tea supplementation suppresses fatty acid synthase expression in the rat liver through downregulating Akt and JNK signalings as demonstrated in human hepatoma HepG2 cells. Oncol. Res. 2005, 16, 119-128.
37. Lee, S. F., Lin, J. K., Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr. Cancer 1997, 28, 177-183.
38. Lee, H. B., Yu, M. R., Song, J. S., Ha, H., Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int. 2004, 65, 1170-1179.
39. Idris, I., Gray, S., Donnelly, R., Protein kinase C activation: Isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001, 44, 659-673.
40. Lin, C. L., Huang, H. C., Lin, J. K., Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J. Lipid Res. 2007, 48, 2334-2343.
41. Zang, M., Xu, S., Maitland-Toolan, K. A., Zuccollo, A. et al., Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55, 2180-2191.
42. Witters, L. A., Kemp, B. E., Means, A. R., Chutes and Ladders: The search for protein kinases that act on AMPK. Trends Biochem. Sci. 2006, 31, 13-16.